Mark Westwood, Lisa J Anderson, Dudley J Pennell. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Cardiomyopathies/diagnosisCardiomyopathies/drug therapyCardiomyopathies/etiologyDeferiproneDeferoxamine/therapeutic useDrug Therapy, CombinationHeart Diseases/epidemiologyHeart Diseases/etiologyHeart Diseases/mortalityHumansIron/analysisIron Chelating Agents/therapeutic useIron Overload/diagnosisIron Overload/drug therapyIron Overload/etiologyLiver/chemistryMyocardium/chemistryPyridones/therapeutic usebeta-Thalassemia/complications
Substances： See more » Iron Chelating AgentsPyridonesDeferiproneIronDeferoxamine
Year: 2003 PMID： 12745264
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941